Board Change • Jun 01
High number of new directors Executive Director You Liew was the last director to join the board, commencing their role in 2026. Reported Earnings • May 31
Third quarter 2026 earnings released: RM0.002 loss per share (vs RM0.002 profit in 3Q 2025) Third quarter 2026 results: RM0.002 loss per share (down from RM0.002 profit in 3Q 2025). Revenue: RM29.7m (down 34% from 3Q 2025). Net loss: RM431.0k (down 165% from profit in 3Q 2025). Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings. New Risk • Mar 02
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 0.6% Last year net profit margin: 1.6% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 20% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (7.9% average weekly change). Profit margins are more than 30% lower than last year (0.6% net profit margin). Market cap is less than US$100m (RM72.9m market cap, or US$18.7m). Reported Earnings • Mar 02
Second quarter 2026 earnings released: RM0.003 loss per share (vs RM0.002 profit in 2Q 2025) Second quarter 2026 results: RM0.003 loss per share (down from RM0.002 profit in 2Q 2025). Revenue: RM28.2m (down 38% from 2Q 2025). Net loss: RM948.0k (down 242% from profit in 2Q 2025). Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has increased by 12% per year, which means it is well ahead of earnings. Announcement • Feb 11
Datin Lin Ching Yein and Datuk Loh Saw Foong proposed to acquire an additional 59.99% stake in Thye On Tong Trading Sdn Bhd from PeterLabs Holdings Berhad (KLSE:PLABS) for MYR 6.9 million. Datin Lin Ching Yein and Datuk Loh Saw Foong proposed to acquire an additional 59.99% stake in Thye On Tong Trading Sdn Bhd from PeterLabs Holdings Berhad (KLSE:PLABS) for MYR 6.9 million on February 10, 2026. Datin Lin Ching Yein holds 18% and Datuk Loh Saw Foong holds 22% in Thye On Tong Trading Sdn Bhd.
UOB Kay Hian Sdn. Bhd. acted as financial advisor for PeterLabs Holdings Berhad. Reported Earnings • Nov 29
First quarter 2026 earnings released: EPS: RM0.006 (vs RM0.003 in 1Q 2025) First quarter 2026 results: EPS: RM0.006 (up from RM0.003 in 1Q 2025). Revenue: RM32.8m (down 21% from 1Q 2025). Net income: RM1.66m (up 117% from 1Q 2025). Profit margin: 5.1% (up from 1.8% in 1Q 2025). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has increased by 6% per year, which means it is well ahead of earnings. Announcement • Oct 30
PeterLabs Holdings Berhad, Annual General Meeting, Dec 30, 2025 PeterLabs Holdings Berhad, Annual General Meeting, Dec 30, 2025, at 15:00 Singapore Standard Time. Location: springs i, nilai springs resort hotel, pt4770, nilai springs, negeri sembilan darul khusus, 71800 putra nilai Malaysia Reported Earnings • Aug 31
Full year 2025 earnings released: EPS: RM0.005 (vs RM0.012 in FY 2024) Full year 2025 results: EPS: RM0.005 (down from RM0.012 in FY 2024). Revenue: RM160.9m (down 11% from FY 2024). Net income: RM1.49m (down 56% from FY 2024). Profit margin: 0.9% (down from 1.9% in FY 2024). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 24% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings. Announcement • Jul 10
PeterLabs Holdings Berhad Provides Update on Material Litigation PeterLabs Holdings Berhad has on 4 July 2025, received an Originating Summons ("OS") from Datuk Loh Saw Foong and Datin Lin Chin Yein ("Plaintiffs") against the following person, hereinafter referred to as Defendants: 1. Lim Tai Soon 2. Loh Poh Im 3. Ho Siew Li 4. Ng Boon Siong 5. Yap Siaw Peng 6. Teo Chin Heng 7. Lim Tong Seng 8. Peterlabs Holdings Berhad 9. Thye On Tong Trading Sdn Bhd 10. Peterlabs Sdn Bhd 11. Maisarah Engineering Consultancy Sdn Bhd 12. Maisarah Engineering Sdn Bhd The OS is in relation to the following: (A) A declaration made by the Plaintiffs against the Defendants:(i) The affairs of the 8th Defendant are being conducted or the powers of the directors are being exercised in a manner oppressive and/or disregard of the Plaintiff' interest. (ii) The affairs of the 9th Defendant are being conducted or the powers of the directors are being exercised in a manner oppressive and/or disregard of the Plaintiffs' interest. (iii) The affairs of the 10th Defendant are being conducted or the powers of the directors are being exercised in a manner oppressive and/or disregard of the Plaintiffs' interest. (iv) The various acts and conducts of the 1st to 7th Defendants, assisted or aided by the 11th and 12th Defendants, have been done or are threatened to be done which have and/or will unfairly discriminate against and/or which are and/or will be otherwise prejudicial to the Plaintiffs. (B) An order that the 1st to 7th Defendants as well as the 11th and 12th Defendants to fully account for the sum of MYR 6,400,000.00 and to refund and/or restore the same to the 10th Defendant. (C) An order that an extraordinary general meeting of the 8 Defendant be convened and held upon such terms and conditions as maybe directed by this Honourable Court. (D) An order for the interim preservation of status quo pending the determination of this Originating Summons as to the following: (i) Any changes in the board composition, the capital and any transactions (not involving the ordinary day to day transaction) involving 8th, 9th and/or 10th Defendants. (ii) Detention and preservation of the sum of MYR 6,400,000.00 transferred out of the banking account of the 10th Defendant whenever it is and in whatever form it is. (E) Such further and other relief as deemed fit and proper by this Honourable Court. STEPS TAKEN AND PROPOSED TO BE TAKEN BY THE COMPANY IN RESPECT OF THE OS The Company will be obtaining the necessary legal advice from solicitors with regards to the above OS filed by the Applicant to review the matter before deciding the next course of action to be taken. The Company cautions that any news reporting or public statements containing false allegations, misleading narratives, or inaccurate facts that may cause reputational harm or market confusion will be met with appropriate legal action to protect the Company, its Board, and its shareholders. Board Change • Jun 21
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent & Non Executive Chairman Tai Lim was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Announcement • Jun 20
Peterlabs Holdings Berhad Appoints Ng Lai Yee as Company Secretary, Effective June 17, 2025 Peterlabs Holdings Berhad announced the appointment of Ng Lai Yee as Company Secretary, effective June 17, 2025. Board Change • Jun 11
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent & Non Executive Chairman Tai Lim was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. New Risk • Jun 03
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Malaysian stocks, typically moving 13% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (13% average weekly change). Earnings have declined by 7.6% per year over the past 5 years. Minor Risk Market cap is less than US$100m (RM90.8m market cap, or US$21.4m). Announcement • May 15
PeterLabs Holdings Berhad Announces Removal of Directors PeterLabs Holdings Berhad received a notice on May 15, 2025, from Mr. Bu Yaw Seng and Datin Lin Ching Yein, who jointly hold more than 10% of the issued share capital of the Company, requesting the convening of an Extraordinary General Meeting (EGM) to consider and pass resolutions for the removal and appointment of directors. The resolutions include the removal of Lim Tong Seng, Teo Chin Heng, Yap Siaw Peng, Dato' Lim Tai Soon, Dato' Ng Boon Siong, Ho Siew Li, and Ng Kau as directors with immediate effect. Additionally, any persons appointed by the Board to fill casual vacancies between the notice date and the EGM are to be removed. This announcement is dated May 15, 2025. Reported Earnings • Mar 02
Full year 2024 earnings released: EPS: RM0.01 (vs RM0.013 in FY 2023) Full year 2024 results: EPS: RM0.01 (down from RM0.013 in FY 2023). Revenue: RM176.0m (down 5.5% from FY 2023). Net income: RM2.84m (down 18% from FY 2023). Profit margin: 1.6% (down from 1.9% in FY 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings. New Risk • Dec 20
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Malaysian stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 5.9% per year over the past 5 years. Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (6.9% average weekly change). Large one-off items impacting financial results. Market cap is less than US$100m (RM55.0m market cap, or US$12.2m). Reported Earnings • Nov 30
Third quarter 2024 earnings released: EPS: RM0.003 (vs RM0.005 in 3Q 2023) Third quarter 2024 results: EPS: RM0.003 (down from RM0.005 in 3Q 2023). Revenue: RM41.6m (down 10% from 3Q 2023). Net income: RM767.0k (down 39% from 3Q 2023). Profit margin: 1.8% (down from 2.7% in 3Q 2023). Over the last 3 years on average, earnings per share has fallen by 21% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings. Reported Earnings • Aug 31
Second quarter 2024 earnings released: EPS: RM0.002 (vs RM0.002 in 2Q 2023) Second quarter 2024 results: EPS: RM0.002 (in line with 2Q 2023). Revenue: RM42.8m (down 6.5% from 2Q 2023). Net income: RM583.0k (down 4.4% from 2Q 2023). Profit margin: 1.4% (up from 1.3% in 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings. Reported Earnings • Jun 04
First quarter 2024 earnings released: EPS: RM0.003 (vs RM0.003 in 1Q 2023) First quarter 2024 results: EPS: RM0.003 (in line with 1Q 2023). Revenue: RM46.3m (down 3.3% from 1Q 2023). Net income: RM826.0k (flat on 1Q 2023). Profit margin: 1.8% (in line with 1Q 2023). Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has only fallen by 7% per year, which means it has not declined as severely as earnings. New Risk • Mar 02
New major risk - Revenue and earnings growth Earnings have declined by 1.2% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Payout ratio: 0% Paying a dividend despite having no free cash flows. Earnings have declined by 1.2% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (7.9% average weekly change). Market cap is less than US$100m (RM55.0m market cap, or US$11.6m). Reported Earnings • Mar 02
Full year 2023 earnings released: EPS: RM0.013 (vs RM0.013 in FY 2022) Full year 2023 results: EPS: RM0.013 (in line with FY 2022). Revenue: RM186.2m (up 15% from FY 2022). Net income: RM3.45m (down 4.4% from FY 2022). Profit margin: 1.9% (down from 2.2% in FY 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings. Reported Earnings • Dec 01
Third quarter 2023 earnings released: EPS: RM0.005 (vs RM0.003 in 3Q 2022) Third quarter 2023 results: EPS: RM0.005 (up from RM0.003 in 3Q 2022). Revenue: RM46.3m (up 20% from 3Q 2022). Net income: RM1.27m (up 55% from 3Q 2022). Profit margin: 2.7% (up from 2.1% in 3Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has only fallen by 7% per year, which means it has not declined as severely as earnings. New Risk • Nov 22
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Malaysian stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by earnings (0% payout ratio). Share price has been volatile over the past 3 months (6.9% average weekly change). Profit margins are more than 30% lower than last year (1.7% net profit margin). Market cap is less than US$100m (RM49.5m market cap, or US$10.6m). New Risk • Oct 09
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: RM46.8m (US$9.89m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (RM46.8m market cap, or US$9.89m). Minor Risks Dividend is not well covered by earnings (0% payout ratio). Profit margins are more than 30% lower than last year (1.7% net profit margin). Reported Earnings • Aug 31
Second quarter 2023 earnings released: EPS: RM0.002 (vs RM0.003 in 2Q 2022) Second quarter 2023 results: EPS: RM0.002 (down from RM0.003 in 2Q 2022). Revenue: RM45.7m (up 11% from 2Q 2022). Net income: RM610.0k (down 28% from 2Q 2022). Profit margin: 1.3% (down from 2.0% in 2Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings. Announcement • Jun 02
Peterlabs Holdings Berhad Announces Appointment of Dato Lim Tai Soon Independent and Non Executive Chairman PeterLabs Holdings Berhad announced appointment of Dato Lim Tai Soon Independent and Non Executive Chairman. Date of change is 01 June 2023. Qualifications: Diploma: Diploma in Accounting, Economics and Commerce, Cyma College. Working experience and occupation: Dato' Lim Tai Soon is one of the pioneers of the Malaysian animal health industry. Dato' Lim is the Executive Chairman of the Lintrachem group of companies which he founded in 1983 to import and distribute animal health products and equipment for poultry and livestock. The group has since exited the animal health business and currently focuses on property development and investment. Dato' Lim holds the esteemed position of founding President for the Malaysia Animal Health and Nutrition Association (MAHNiA). As President, he dedicated 16 years to representing and advocating for the interests of the local animal health and nutrition industry. He also continues to contribute as the Honorary Life President of MAHNiA. Dato' Lim has also served the broader business community through his active participation in the Associated Chinese Chambers of Commerce and Industry Malaysia. As a Council Member, he played a pivotal role as the Deputy Chairman of the Commerce Committee for six years. Dato' Lim served as a Council Member of the Malaysia-China Chamber of Commerce until the year 2016. Dato' Lim is active in Kuala Lumpur and Selangor Chinese Chamber of Commerce and Industry (KLSCCCI). Dato' Lim was the Deputy Chairman of KLSCCCI Agriculture Committee from 2006 - 2012 and Chairman of KLSCCCI Education Committee from 2012 - 2018. Dato' Lim has been an engaged as a Council Member of KLSCCCI since the year 2000 until present. Dato' Lim also serves as an Advisor to the KLSCCCI Education Committee and the committee for the Malaysian Chinese Literature Award. Reported Earnings • Jun 01
First quarter 2023 earnings released: EPS: RM0.003 (vs RM0.004 in 1Q 2022) First quarter 2023 results: EPS: RM0.003 (down from RM0.004 in 1Q 2022). Revenue: RM47.9m (up 17% from 1Q 2022). Net income: RM832.0k (down 33% from 1Q 2022). Profit margin: 1.7% (down from 3.0% in 1Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has remained flat, which means it is well ahead of earnings. Announcement • May 31
PeterLabs Holdings Berhad Announces Retirement of Dato Hon Choon Kim Independent and Non Executive Chairman PeterLabs Holdings Berhad announced retirement of Dato Hon Choon Kim Independent and Non Executive Chairman. Date of change is 30 May 2023. Age is 74. Reported Earnings • Mar 02
Full year 2022 earnings released: EPS: RM0.013 (vs RM0.021 in FY 2021) Full year 2022 results: EPS: RM0.013 (down from RM0.021 in FY 2021). Revenue: RM161.6m (down 12% from FY 2021). Net income: RM3.60m (down 34% from FY 2021). Profit margin: 2.2% (down from 3.0% in FY 2021). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 4% per year whereas the company’s share price has remained flat. Reported Earnings • Dec 03
Third quarter 2022 earnings released: EPS: RM0.003 (vs RM0.006 in 3Q 2021) Third quarter 2022 results: EPS: RM0.003 (down from RM0.006 in 3Q 2021). Revenue: RM38.6m (down 17% from 3Q 2021). Net income: RM815.0k (down 47% from 3Q 2021). Profit margin: 2.1% (down from 3.3% in 3Q 2021). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has remained flat whereas the company’s share price has increased by 3% per year. Board Change • Nov 16
High number of new directors There are 5 new directors who have joined the board in the last 3 years. Independent Non-Executive Director Siew Ho was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Aug 31
Second quarter 2022 earnings released: EPS: RM0.003 (vs RM0.003 in 2Q 2021) Second quarter 2022 results: EPS: RM0.003 (vs RM0.003 in 2Q 2021). Revenue: RM41.4m (down 11% from 2Q 2021). Net income: RM848.0k (down 4.9% from 2Q 2021). Profit margin: 2.0% (up from 1.9% in 2Q 2021). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 2% per year and the company’s share price has also increased by 2% per year. Board Change • Aug 01
High number of new directors There are 5 new directors who have joined the board in the last 3 years. Independent Non-Executive Director Siew Ho was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Announcement • Jun 21
Peterlabs Holdings Berhad Announces Single Tier Interim Dividend for the Fiscal Year Ending 31 December, 2022, Payable on July 22, 2022 PeterLabs Holdings Berhad announced single tier interim dividend of MYR 0.006 per ordinary share for the fiscal year ending 31 December, 2022. Ex-date is 14 July, 2022. Entitlement date is 15 July, 2022. Payment date is July 22, 2022. Announcement • Jun 02
Peterlabs Holdings Berhad Announces Resignation of Wong Yuet Chyn as Company Secretary PeterLabs Holdings Berhad announced the resignation of Wong Yuet Chyn as Company Secretary. Date Of Change 01 June 2022. Reported Earnings • Jun 01
First quarter 2022 earnings released: EPS: RM0.004 (vs RM0.005 in 1Q 2021) First quarter 2022 results: EPS: RM0.004 (down from RM0.005 in 1Q 2021). Revenue: RM41.0m (down 16% from 1Q 2021). Net income: RM1.23m (down 7.8% from 1Q 2021). Profit margin: 3.0% (up from 2.7% in 1Q 2021). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 2% per year whereas the company’s share price has fallen by 1% per year. Announcement • May 02
PeterLabs Holdings Berhad, Annual General Meeting, Jun 29, 2022 PeterLabs Holdings Berhad, Annual General Meeting, Jun 29, 2022, at 11:30 Singapore Standard Time. Location: Boardroom, 16014 (PT No. 24341), Jalan Nilam 3 Bandar Nilai Utama 71800 Nilai, Negeri Sembilan Darul Khusus Malaysia Malaysia Agenda: To receive the Audited Financial Statements for the financial year ended 31 December 2021 together with the Reports of the Directors and Auditors thereon; to approve the payment of Directors' fees of up to MYR 127,200 for the financial year ended 31 December 2021; to re-appoint Messrs. Grant Thornton Malaysia as Auditors of the Company for the financial year ending 31 December 2022 at such remuneration to be determined by the Directors; and to consider any other matters. Announcement • Mar 03
Peterlabs Holdings Berhad Announces Appointment of YOUNG WOU JIAN as Company Secretary PeterLabs Holdings Berhad announced appointment of YOUNG WOU JIAN as Company Secretary. Date Of Change is 01 March 2022. Reported Earnings • Mar 02
Full year 2021 earnings: EPS in line with expectations, revenues disappoint Full year 2021 results: EPS: RM0.02 (up from RM0.017 in FY 2020). Revenue: RM183.2m (up 129% from FY 2020). Net income: RM5.48m (up 41% from FY 2020). Profit margin: 3.0% (down from 4.9% in FY 2020). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 3.5%. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings. Reported Earnings • Dec 01
Third quarter 2021 earnings: EPS in line with expectations, revenues disappoint Third quarter 2021 results: EPS: RM0.006 (vs RM0.006 in 3Q 2020). Revenue: RM46.6m (up 131% from 3Q 2020). Net income: RM1.63m (up 33% from 3Q 2020). Profit margin: 3.5% (down from 6.1% in 3Q 2020). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 3.5%. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings. Reported Earnings • Oct 01
Second quarter 2021 earnings released: EPS RM0.003 (vs RM0.004 in 2Q 2020) The company reported a solid second quarter result with improved earnings and revenues, although profit margins were weaker. Second quarter 2021 results: Revenue: RM46.4m (up 142% from 2Q 2020). Net income: RM892.0k (up 17% from 2Q 2020). Profit margin: 1.9% (down from 4.0% in 2Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings. Reported Earnings • Jun 30
First quarter 2021 earnings released: EPS RM0.005 (vs RM0.004 in 1Q 2020) The company reported a solid first quarter result with improved earnings and revenues, although profit margins were weaker. First quarter 2021 results: Revenue: RM49.0m (up 125% from 1Q 2020). Net income: RM1.34m (up 47% from 1Q 2020). Profit margin: 2.7% (down from 4.2% in 1Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has remained flat whereas the company’s share price has fallen by 5% per year. Reported Earnings • Jun 06
Full year 2020 earnings released: EPS RM0.017 (vs RM0.02 in FY 2019) The company reported a soft full year result with weaker earnings and revenues, although profit margins were improved. Full year 2020 results: Revenue: RM80.0m (down 17% from FY 2019). Net income: RM3.89m (down 9.1% from FY 2019). Profit margin: 4.9% (up from 4.4% in FY 2019). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has remained flat whereas the company’s share price has fallen by 2% per year. Reported Earnings • Mar 16
Full year 2020 earnings released: EPS RM0.016 (vs RM0.02 in FY 2019) The company reported a soft full year result with weaker earnings and revenues, although profit margins were improved. Full year 2020 results: Revenue: RM80.0m (down 17% from FY 2019). Net income: RM3.86m (down 9.8% from FY 2019). Profit margin: 4.8% (up from 4.4% in FY 2019). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings. Announcement • Jan 17
PeterLabs Holdings Berhad (KLSE:PLABS) completed the acquisition of 60% stake in THYE ON TONG TRADING SDN BHD from Datuk Loh Saw Foong and Datin Lin Ching Yein. PeterLabs Holdings Berhad (KLSE:PLABS) signed a conditional share sale agreement to acquire 60% stake in THYE ON TONG TRADING SDN BHD from Datuk Loh Saw Foong and Datin Lin Ching Yein for MYR 14.5 million on July 22, 2020. The consideration will be paid in MYR 3 million cash and 39 million shares of PeterLabs. Directors of THYE ON, Datuk Loh and Datin Lin will sell 30% stake each and will receive equal consideration of MYR 1.5 million in cash and 19.5 million shares each. As a result of the transaction Datuk Loh Saw and Datin Lin Ching will hold 18% stake each in THYE ON TONG. 10% of the Purchase Consideration amounting to MYR 1.08 million in cash shall be paid to the Datuk and Datin in equal proportions on the date of the agreement, the remaining cash consideration of MYR 1.92 million shall be paid to Datuk and Datin in equal proportions on the completion date, an aggregate of 25.5 million consideration shares shall be issued and allotted to the Datuk and Datin in equal proportions on the completion Date. The remaining of 13.5 million consideration shares shall be issued to Pacific Trustees Berhad, the security trustee jointly appointed by the PeterLabs and the Datuk and Datin on the completion date and transferred by the Trustee to the Vendors in equal proportions in the manner as set. The Retained Consideration Shares shall be released to the Vendors in 2 tranches by the Trustee. Upon finalization of THYE ON TONG’s audited financial statements for the FYE 2021, the parties agree that the company shall within 14 business days from the date of filing of THYE ON TONG’s financial statements for the FYE 2021 and second tranche upon finalization of audited financial statements for the FYE 2022. The Cash Consideration shall be funded via the proceeds raised from a proposed private placement undertaken by the Company, announced on July 13, 2020 and / or internally generated funds of the PeterLabs. The Purchase Consideration was arrived at on a “willing-buyer willing-seller” basis based on the price to earnings multiple (“PE Multiple”) of 8 times. For the year ended December 31, 2019, THYE ON TONG recorded Revenue of MYR 50.03 million, profit after tax and Net assets of MYR 0.58 million and MYR 5.70 million respectively.
The transaction is conditional on legal due diligence to be conducted on THYE ON. The approval-in-principle of Bursa Securities for the listing of and quotation for the completion consideration shares and retained consideration shares on the ACE Market of Bursa Securities. The execution of sale and purchase agreements for the sale of the properties to Datuk Loh Saw Foong and Datin Lin Ching Yein and/or such investment holding company, execution of executive service agreement for a period of 5 years between Datuk Loh Saw Foong and THYE ON TONG, execution of escrow agreement, approval of shareholders of PeterLabs, consents or approvals as may be necessary from any governmental or regulatory body or competent authority, financiers, brand principals or third-party. As of September 4, 2020, Bursa Malaysia Securities Berhad approved the listing and quotation of 39 million shares to be issued pursuant to the transaction. Subject to fulfilment of the conditions Precedent and the terms and conditions of the agreement, the completion will take place on 14 days from the date the agreement becomes unconditional unless the parties agree otherwise in writing. The transaction is expected to be closed by the 4th quarter of 2020. As on September 7, 2020, the board of directors of PeterLabs Holdings recommends the shareholders to vote in favour of the acquisition. The transaction will not have any immediate effect on the consolidated earnings and EPS of the PeterLabs for the FYE 2019. However, the transaction is expected to contribute positively to the future earnings of the PeterLabs. Alliance Investment Bank Berhad acted as financial advisor for PeterLabs.
PeterLabs Holdings Berhad (KLSE:PLABS) completed the acquisition of 60% stake in THYE ON TONG TRADING SDN BHD from Datuk Loh Saw Foong and Datin Lin Ching Yein on January 15, 2021. Reported Earnings • Dec 01
Third quarter 2020 earnings released: EPS RM0.006 The company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2020 results: Revenue: RM20.1m (down 17% from 3Q 2019). Net income: RM1.23m (up 7.4% from 3Q 2019). Profit margin: 6.1% (up from 4.7% in 3Q 2019). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings. Is New 90 Day High Low • Oct 30
New 90-day low: RM0.21 The company is down 9.0% from its price of RM0.23 on 30 July 2020. The Malaysian market is down 4.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Pharmaceuticals industry, which is up 19% over the same period. Is New 90 Day High Low • Oct 15
New 90-day low: RM0.21 The company is down 7.0% from its price of RM0.23 on 17 July 2020. The Malaysian market is up 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Pharmaceuticals industry, which is up 43% over the same period. 
